VIVE — Vivesto AB Share News
0.000.00%
- SEK95.10m
- SEK63.62m
Brief: Vivesto Q1 Net Loss After Tax Narrows To SEK 20.4 Mln
Brief: Vivesto Q1 Operating Profit at SEK -21.537 Million
Brief: Vivesto, Elevar Seek to Transfer Apealea Rights
Brief: Vivesto Initiates Clinical Development Of Paccal Vet In Veterinary Oncology
Brief: Vivesto Q4 Oper Loss Widens To SEK 31.0 Mln
Brief: Vivesto Q4 EPS at SEK -0.06
Brief: Vivesto: Inceptua Decides To Withdraw Market Authorization Application For Apealea In Switzerland
Brief: Vivesto Announces Erik Kinnman As New CEO From January
Brief: Vivesto's Acting CEO Stays In Position During Transition Period
Brief: Vivesto Appoints Erik Kinnman As CEO
Brief: Vivesto Q3 Oper Result Turns To Profit Of SEK 71.3 Mln
Brief: Vivesto Acting CEO Christer Nordstedt Resigns
Brief: Vivesto Q2 Operating Loss Narrows To SEK 36.3 Mln
Brief: Vivesto Appoints Christer Nordstedt As Acting CEO
Brief: Vivesto Winds Down Its Activities In Russia
Brief: Vivesto Appoints Robert Maiorana As Acting CFO
Brief: Vivesto And CEO Francois Martelet Have Agreed On Ending Employment Relationship
Brief: Vivesto Q1 Operating Loss Narrows To SEK 26.3 Mln
Brief: Vivesto Proposes Peter Zonabend As Chairman